Skip to content
Review Open access

Presenilin Deficiency Beyond Amyloid: Lessons from Presenilin 1/2 Conditional Double-Knockout Mice on Synaptic Failure, Calcium Dyshomeostasis, and Inflammation-Driven Alzheimer's disease.

Jul 2026 · Brain Research Bulletin · Vol 244, pp. 112057 · 0 citations · 117 references
Medicine

TL;DR

It is concluded that PS integrate vesicular release machinery with trophic and inflammatory homeostasis; their loss initiates a multi-scale failure cascade that redefines early AD-related neurodegeneration beyond Aβ.

Abstract

Presenilins are best known as the catalytic core of γ-secretase, where familial Alzheimer's disease (FAD) mutations shift amyloid-β (Aβ) trimming toward aggregation-prone species. Yet conditional and cell-type-specific genetic analyses in mice now place presenilin (PS) biology far beyond amyloidogenesis. In PS1/PS2 conditional double-knockout (PS cDKO) models, where presenilins are inactivated postnatally in forebrain excitatory neurons, the earliest phenotype is a synaptopathy: presynaptic release probability and short-term plasticity collapse, N-methyl-D-aspartate receptor (NMDAR) function wanes, and cAMP response element-binding protein (CREB)/CREB-binding protein (CBP)-dependent transcriptional programs falter. Compensatory glial responses rapidly consolidate into a neuroinflammatory state, with inflammasome activation and cytokine surges that further erode synaptic signaling and promote tau hyperphosphorylation. Progressive cortical and callosal atrophy and ventriculomegaly follow, culminating in neuron loss, even as cortical Aβ is reduced, severing the mechanistic necessity of plaques for degeneration. Across interventions, anti-inflammatory, cholinergic, and metabolic manipulations rescue cognition and plasticity in PS cDKO mice without engaging amyloid, underscoring a disease axis that is Aβ-independent yet clinically salient. Here we synthesize lessons from PS cDKO studies, integrate them with contemporary presenilins/γ-secretase biology, and outline a translational agenda focused on presynaptic Ca2+ microdomains, RyR-coupled release, activity-dependent gene programs, and innate immune checkpoints. We conclude that PS integrate vesicular release machinery with trophic and inflammatory homeostasis; their loss initiates a multi-scale failure cascade that redefines early AD-related neurodegeneration beyond Aβ.

Read PDF

Similar papers

Review Open access Aug 2026

Adaptive-to-maladaptive IRE1α signaling as a driver of amyloidogenic APP processing in Alzheimer’s disease

How dynamic changes in IRE1α signaling bias contribute to amyloidogenic progression in AD is examined and whether selective modulation of adaptive versus maladaptive IRE1α outputs may offer stage-dependent therapeutic benefit is considered.

Dan-Yun Wang, Qinan Yin · 0 citations
Review Open access Aug 2026

P2X7 receptor-dependent microglia-astrocyte coupling in Alzheimer's disease: from eATP sensing to synaptic and proteostatic failure

Alzheimer's disease (AD) is characterized not only by amyloid-β and tau pathology but also by progressive failure of multicellular homeostasis. The P2X7 receptor (P2X7R), a low-affinity ATP-gated ion channel preferentially activated in extracellular ATP-rich pathological microenvironments, is well positioned to transla...

Yiwen Li, Shi-Ming Liu, Jiao Lan · 0 citations
Open access Aug 2026

β-Arrestin2 Drives Sex-Specific Akt/GSK3β Signaling, Aβ Pathology, and Cognitive Decline in Alzheimer’s Disease Mice

These findings identify β- arrestin2 as a sex-dependent node linking Aβ pathology to cognitive outcomes in males but not females, underscoring the necessity of sex-stratified consideration in the design of GPCR-targeted Alzheimer’s disease therapeutics.

Fatemeh A. Panahi, Fatemeh Babaei, Tash-Lynn L. Colson et al. · 0 citations
Review Aug 2026

Epitranscriptomic imprints on glial cell polarization: METTL3/IGF2BP2 axis as a driver of neurodegeneration in Alzheimer's disease.

New mechanistic truths of how m6A-dependent RNA regulation contributes to the progression of AD are compiled and therapeutic opportunities of METTL3/IGF2BP2 axis targeting for novel RNA-based therapies for neurodegenerative disease are discussed.

Neha, K. Aran · 0 citations
Open access Aug 2026

TRIM9 Determines Sex-Specific β-Amyloid/Cellular Prion Protein/mGluR5 Complex Formation and Pathological Signaling in Alzheimer’s Disease Mice

Biological sex is a major determinant of Alzheimer’s disease prevalence, yet the molecular mechanisms underlying sex-specific vulnerability remain largely unknown. Metabotropic glutamate receptor 5 (mGluR5) functions as a co-receptor for β-amyloid (Aβ42) oligomer/cellular prion protein (PrPC)-mediated pathogenic signal...

Fatemeh Babaei, Fatemeh A. Panahi, Tash-Lynn L. Colson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.